← All trials
NCT01848873
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Aug 1, 2013
- Completion date
- Aug 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 756
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Shenzhen Ausa Pharmed Co.,LtdLead sponsor
- Peking UniversityOverall official - principal investigator
- Capital Medical UniversityCollaborator
- Fudan UniversityCollaborator
- Nanchang UniversityCollaborator
- Xuzhou Medical UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Shantou UniversityCollaborator
- Sichuan UniversityCollaborator
- China Medical UniversityCollaborator
- Fujian Medical UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Peking UniversityCollaborator
- Zhejiang UniversityCollaborator
- People's Liberation Army of ChinaCollaborator
- Jiao Tong UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.